【行情】生物制药公司Arcus Biosciences盘后涨幅扩大至47.3%,报道称吉利德据悉正就收购该公司股份进行谈判。网页链接查看全文
牛唐2019-05-13 16:45
$Arcus Biosciences(RCUS)$ 明星公司终于在6月底前迎来一期topline data的发布,GV、高瓴的眼光能否得到证实吗$谷歌A(GOOGL)$ $百济神州(BGNE)$查看全文
牛唐2018-06-30 11:22
$Infinity Pharmaceuticals, Inc. (INFI)$ $Arcus Biosciences, Inc.(RCUS)$ 两家公司达成合作的两组triple combination:IPI-549+AB928+AB122、IPI-549+AB928+化疗,准备在竞争激烈的TNBC和卵巢癌领域开展联合治疗查看全文
牛唐2018-04-18 08:11
$Arcus Biosciences(RCUS)$ 根据披露的数据,AB928在临床一期中显示出较好的耐受性,且未出现安全问题。接下来,AB928将和三种不同的化疗疗法和AB122(与药明康德合作的PD-1)进行联合用药试验,具体适应症有可能是非小细胞肺癌、肾癌、食道癌、结直肠癌、卵巢癌或三阴性乳腺癌。计划2019年上半年...查看全文
淘沙见金2018-04-16 11:07
Most solid tumors need to have T cells generated BEFORE other immune therapies. Next wave of IO? Lag-3? Tim-3? TIGIT? $OncoMed Pharmaceuticals, Inc.(OMED)$ $Arcus Biosciences(RCUS)$查看全文
淘沙见金2018-04-09 11:00
然后Terry Rosen和Juan Jaen拿到天价收购费用后自己拉了一帮旧部跑去成立了 $Arcus Biosciences(RCUS)$ ....查看全文
智通财经APP获悉,今日,吉利德科学(GILD.US)和Arcus Biosciences(RCUS.US)在2023年美国临床肿瘤学会(ASCO)年会当中公布了针对转移性非小细胞肺癌(NSCLC)患者的2期临床试验ARC-7的最新中期分析结果。结果显示,在肿瘤高度表达PD-L1... 网页链接
格隆汇5月26日丨Arcus Biosciences (RCUS.US)涨11.43%,报19.5美元。瑞穗证券重申对Arcus Biosciences的”买入”评级,目标价51美元。 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000126 Size: 4 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000127 Size: 4 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000128 Size: 5 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000129 Size: 4 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000110 Size: 7 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000112 Size: 6 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000114 Size: 7 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000111 Size: 7 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000113 Size: 7 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000116 Size: 9 KB 网页链接